Profile

Hi all, Has anyone started using zenocutuzumab? There are different recommendations for infusion duration between the eNRGy1 study and FDA approval - eNRGy1 infused over 4 hours for first dose and then dropped to 2 hours for subsequent doses if no IRR Grade > 2, while FDA approved as 4 hours and does ...

Hi all, I am curious how your outpatient tarlatamab processes have been going more recently? We are hoping to implement a process here soon at Duke. We were planning to closely mirror the DeLLphi-300 substudy, including a clinic visit on day 2/day 9 and nurse phone call on day 3/day 10 with patients ...

Hi! Just curious if anyone has heard another update regarding sunvozertinib access now that we're into 2026? Thanks, Cami